my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Abstract:
Choline is a zwitter ion that is positively charged at certain pH, which necessitates transport systems to allow this amine to cross the phospholipid bilayer of cellular membranes. The solute carrier 44A1 (SLC44A1), also referred to as choline transporter-like protein 1 (CTL1), is a recently discovered choline transporter with an intermediate affinity for choline; this transport is Na+-independent and sensitive to inhibition by the drug hemicholinium-3. We highlight in this review the discovery and characterization of SLC44A1, describe its expression patterns and subcellular localization, and summarize evidence for the role of this choline transporter in the central nervous system.| Authors: | Michel, Vera; Bakovic, Marica | |
| Journal: | Central Nervous System Agents in Medicinal Chemistry | |
| DOI: | 10.2174/187152412800792733 |
Watchlist
This is where you can add this publication to your personal favourites.
Additional Information
Synthetic Methods for the Hydrodehalogenation of Halogenated Heterocycles
Abstract: This review provides an overview of methods that lead to the substitution of halogens from rings of halogenated heterocycles by hydrogen. The first part of the review treats the subject matter from the viewpoint of the method used for the hydrodehalogenation reaction, while ... more
Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Abstract: More needs to be done by the private sector to optimize the drug discovery and development pipeline. In addition, significant efforts should also be focused on the understanding of mechanism of diseases, on the characterization of unexplored biochemical pathways and on the ... more
New Insights in Protein Kinase Conformational Dynamics
Abstract: A significant portion of recent drug development efforts has been focused on protein kinases. More than a hundred different compounds are currently under clinical trials and nearly 30% of all the scientific articles in drug discovery are on protein kinase inhibitors. Protei ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
